Michael Geffner
Direttore Tecnico/Scientifico/R&S presso IMMUNOVANT, INC.
Patrimonio netto: 4 M $ in data 31/05/2024
Posizioni attive di Michael Geffner
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IMMUNOVANT, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Michael Geffner
Precedenti posizioni note di Michael Geffner
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | 28/01/2020 |
Formazione di Michael Geffner
| Albany Medical College | Doctorate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
- Borsa valori
- Insiders
- Michael Geffner
- Esperienza
